Literature DB >> 17599554

The transcription factors Stat5a/b are not required for islet development but modulate pancreatic beta-cell physiology upon aging.

Ji-Yeon Lee1, Oksana Gavrilova, Behrous Davani, Risu Na, Gertraud W Robinson, Lothar Hennighausen.   

Abstract

In insulinoma cell lines proliferation and insulin gene transcription are stimulated by growth hormone and prolactin, which convey their signals through the transcription factors Stat5a and 5b (referred to as Stat5). However, the contribution of Stat5 to the physiology of beta-cells in vivo could not be assessed directly since Stat5-null mice die perinataly. To explore the physiological role of Stat5 in the mouse, the corresponding gene locus targeted with loxP sites was inactivated in beta-cells using two lines of Cre recombinase expressing transgenic mice. While the RIP-Cre transgene is active in pancreatic beta-cells and the hypothalamus, the Pdx1-Cre transgene is active in precursor cells of the endocrine and exocrine pancreas. Mice carrying two floxed Stat5alleles and a RIP-Cre transgene developed mild obesity, were hyperglycemic and exhibited impaired glucose tolerance. Since RIP-Cre transgenic mice by themselves display some glucose intolerance, the significance of these data is unclear. In contrast, mice, in which the Stat5 locus had been deleted with the Pdx1-Cre transgene, developed functional islets and were glucose tolerant. Mild glucose intolerance occurred with age. We conclude that Stat5 is not essential for islet development but may modulate beta-cell function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599554      PMCID: PMC2695665          DOI: 10.1016/j.bbamcr.2007.05.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

1.  Expression of dominant-negative STAT5 inhibits growth hormone- and prolactin-induced proliferation of insulin-producing cells.

Authors:  E D Galsgaard; B N Friedrichsen; J H Nielsen; A Møldrup
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

Review 2.  Regulation of beta-cell mass by hormones and growth factors.

Authors:  J H Nielsen; E D Galsgaard; A Møldrup; B N Friedrichsen; N Billestrup; J A Hansen; Y C Lee; C Carlsson
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

3.  Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.

Authors:  Yongzhi Cui; Greg Riedlinger; Keiko Miyoshi; Wei Tang; Cuiling Li; Chu-Xia Deng; Gertraud W Robinson; Lothar Hennighausen
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

4.  Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells.

Authors:  Birgitte N Friedrichsen; Henrijette E Richter; Johnny A Hansen; Christopher J Rhodes; Jens H Nielsen; Nils Billestrup; Annette Møldrup
Journal:  Mol Endocrinol       Date:  2003-02-13

5.  Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance.

Authors:  Michael Freemark; Isabelle Avril; Don Fleenor; Phyllis Driscoll; Ann Petro; Emmanuel Opara; Will Kendall; Jon Oden; Spencer Bridges; Nadine Binart; Bernadette Breant; Paul A Kelly
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

6.  Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans.

Authors:  T Clark Brelje; Laurence E Stout; Nicholas V Bhagroo; Robert L Sorenson
Journal:  Endocrinology       Date:  2004-05-13       Impact factor: 4.736

7.  Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice.

Authors:  Jun-Li Liu; Karen T Coschigano; Katie Robertson; Mark Lipsett; Yubin Guo; John J Kopchick; Ujendra Kumar; Ye Lauren Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05-11       Impact factor: 4.310

8.  Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice.

Authors:  Lisa Héron-Milhavet; Martin Haluzik; Shoshana Yakar; Oksana Gavrilova; Stephanie Pack; William C Jou; Azeddine Ibrahimi; Hyunsook Kim; Desmond Hunt; Daphne Yau; Zeenat Asghar; Jamie Joseph; Michael B Wheeler; Nada A Abumrad; Derek LeRoith
Journal:  Endocrinology       Date:  2004-07-01       Impact factor: 4.736

9.  Role of VEGF-A in vascularization of pancreatic islets.

Authors:  Eckhard Lammert; Guqiang Gu; Margaret McLaughlin; Dennis Brown; Rolf Brekken; Lewis Charles Murtaugh; Hans Peter Gerber; Napoleone Ferrara; Douglas A Melton
Journal:  Curr Biol       Date:  2003-06-17       Impact factor: 10.834

10.  VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.

Authors:  Masahiro Inoue; Jeffrey H Hager; Napoleone Ferrara; Hans-Peter Gerber; Douglas Hanahan
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

View more
  16 in total

1.  The role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus.

Authors:  D Gupta; T Kono; C Evans-Molina
Journal:  Diabetes Obes Metab       Date:  2010-12       Impact factor: 6.577

2.  Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Janus kinase-2 (JAK2)/signal transducer and activator of transcription-5 (STAT5) signalling.

Authors:  N Guthalu Kondegowda; A Mozar; C Chin; A Otero; A Garcia-Ocaña; R C Vasavada
Journal:  Diabetologia       Date:  2012-03-03       Impact factor: 10.122

3.  Growth hormone receptor regulates β cell hyperplasia and glucose-stimulated insulin secretion in obese mice.

Authors:  Yingjie Wu; Chengyu Liu; Hui Sun; Archana Vijayakumar; Pejman Raeisi Giglou; Ruifang Qiao; Joshua Oppenheimer; Shoshana Yakar; Derek LeRoith
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

4.  Brain expression of Cre recombinase driven by pancreas-specific promoters.

Authors:  Junghun Song; Yuanzhong Xu; Xiaoxia Hu; Brian Choi; Qingchun Tong
Journal:  Genesis       Date:  2010-10-19       Impact factor: 2.487

5.  Prolactin Receptor Signaling Regulates a Pregnancy-Specific Transcriptional Program in Mouse Islets.

Authors:  Mark E Pepin; Hayden H Bickerton; Maigen Bethea; Chad S Hunter; Adam R Wende; Ronadip R Banerjee
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

6.  Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1.

Authors:  Marc A Kerenyi; Florian Grebien; Helmuth Gehart; Manfred Schifrer; Matthias Artaker; Boris Kovacic; Hartmut Beug; Richard Moriggl; Ernst W Müllner
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

Review 7.  The different functions of Stat5 and chromatin alteration through Stat5 proteins.

Authors:  Jan-Wilhelm Kornfeld; Florian Grebien; Marc A Kerenyi; Katrin Friedbichler; Boris Kovacic; Barbara Zankl; Andrea Hoelbl; Harini Nivarti; Hartmut Beug; Veronika Sexl; Mathias Muller; Lukas Kenner; Ernst W Mullner; Fabrice Gouilleux; Richard Moriggl
Journal:  Front Biosci       Date:  2008-05-01

Review 8.  Genomic dissection of the cytokine-controlled STAT5 signaling network in liver.

Authors:  Atsushi Hosui; Lothar Hennighausen
Journal:  Physiol Genomics       Date:  2008-05-06       Impact factor: 3.107

9.  CISH has no non-redundant functions in glucose homeostasis or beta cell proliferation during pregnancy in mice.

Authors:  Yang Jiao; Sebastian Rieck; John Le Lay; Klaus H Kaestner
Journal:  Diabetologia       Date:  2013-08-16       Impact factor: 10.122

10.  Sensitized phenotypic screening identifies gene dosage sensitive region on chromosome 11 that predisposes to disease in mice.

Authors:  Olga Ermakova; Lukasz Piszczek; Luisa Luciani; Florence M G Cavalli; Tiago Ferreira; Dominika Farley; Stefania Rizzo; Rosa Chiara Paolicelli; Mumna Al-Banchaabouchi; Claus Nerlov; Richard Moriggl; Nicholas M Luscombe; Cornelius Gross
Journal:  EMBO Mol Med       Date:  2011-01       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.